HIV AIDS

Clinical trials of second generation direct-acting antivirals in HCV show high cure rates. But do those rates reflect real life?

This case study of 2 patients suggests that very early antiretroviral therapy is not enough to prevent formation of latent viral reservoirs and prevent HIV rebound on treatment discontinuation.

Here: a quick look at newly approved agents for primary care that will soon be coming your way.

A systematic approach may help more primary care clinicians identify men who have sex with men among their patients, which in turn could help them focus on patients in need of more frequent HIV testing and preventive services.

"What we need to do now is to help people with HIV realize the full potential of their much-extended life expectancy."

When it comes to cannabis use, one issue is when.

Why has the HIV epidemic shifted from affluent gay white men in New York and San Francisco to impoverished people of color in the South?

While a few studies have suggested that HAART therapy is generally cardioprotective, the long-term impact of prenatal and postnatal exposure on cardiac structure and function has remained unknown. A new study sheds light.

It’s how much cannabis your patients with HIV infection smoke now-not over their lifetime-that appears to affect their cognition.

What does the office-based ECG tell you about the patient's complaint of recently worsening asthenia and dyspnea?